8/28/2005
BOSTON - It appears that a national lawsuit against a number of drug manufacturers that include companies AstraZeneca, Bristol-Myers Squibb and GlaxoSmithKline, will move forward once attorneys for the plaintiffs make technical changes to their complaint. The lawsuit claims that the drug manufacturers routinely inflated the Average Wholesale Price they report to trade publications in order to inflate drug prices and defraud customers.
The lawsuit concerns "all persons who received physician-administered drugs manufactured by the drug companies in question." Of the drugs mentioned, one of particular note is Remicade, a biologic medication recently approved in the treatment of ankylosing spondylitis.
The list of medications includes:
According to Seattle attorney, Steve W. Berman, "Once we prove that thousands, even millions of innocent people have been defrauded and forced to pay inflated prices for their medications, the drug companies will be forced to give an account."
Stay up-to-date on all the latest news and information regarding AS and related diseases with our news magazine, Spondylitis Plus. Your subscription comes free with SAA membership, so click here to join today!